uuid stringlengths 4 8 | template_uuid stringclasses 40
values | question stringlengths 13 193 | answer stringlengths 29 2.2k | benchmark_query stringlengths 133 622 | execution_results stringlengths 2 1.14M | query_type stringclasses 2
values | sql_category stringclasses 26
values | bio_category stringclasses 14
values |
|---|---|---|---|---|---|---|---|---|
Q59.431 | Q59 | What is the genetic target of the small molecule drug Lornoxicam, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Lornoxicam: PTGS2 and PTGS1. Lornoxicam reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%lornoxicam%" OR LOWER(tradeNames_string) LIKE "%lornoxicam%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_5752', 'drugName': 'Lornoxicam', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PTGS2 (ENSG00000073756), PTGS1 (ENSG00000095303)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.657 | Q59 | What is the genetic target of the protein drug Somatropin, and what is its status in clinical trials and FDA approval? | The genetic target of the protein drug Somatropin is GHR. Somatropin reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%somatropin%" OR LOWER(tradeNames_string) LIKE "%somatropin%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_5635', 'drugName': 'Somatropin', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'GHR (ENSG00000112964)', 'yearOfFirstApproval': 1976, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_3230', 'drugName': 'Somatrogon', 'drugMolecularType': 'Protein... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1642 | Q59 | What is the genetic target of the small molecule drug Felbamate, and what is its status in clinical trials and FDA approval? | There are 7 genetic targets of the small molecule drug Felbamate: GRIN1, GRIN2A, GRIN2B, GRIN2D, GRIN3B, GRIN2C, and GRIN3A. Felbamate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%felbamate%" OR LOWER(tradeNames_string) LIKE "%felbamate%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_758', 'drugName': 'Felbamate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'GRIN1 (ENSG00000176884), GRIN2A (ENSG00000183454), GRIN2B (ENSG00000273079), GRIN2D (ENSG00000105464), GRIN3B (ENSG00000116032), GRIN2C (ENSG00000161509), GRIN3A (ENSG00000198785)', 'yearOfFir... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1318 | Q59 | What is the genetic target of the small molecule drug Pheniramine Maleate, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Pheniramine Maleate is HRH1. Pheniramine Maleate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%pheniramine maleate%" OR LOWER(tradeNames_string) LIKE "%pheniramine... | [{'UUID': 'DrugGeneTargets_v2_463', 'drugName': 'Pheniramine Maleate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HRH1 (ENSG00000196639)', 'yearOfFirstApproval': 1994, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_221', 'drugName': 'Chlorpheniramine Maleate', ... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1358 | Q59 | What is the genetic target of the protein drug .Alpha.1-Proteinase Inhibitor Human, and what is its status in clinical trials and FDA approval? | The genetic target of the protein drug .Alpha.1-Proteinase Inhibitor Human is ELANE. .Alpha.1-Proteinase Inhibitor Human reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%.alpha.1-proteinase inhibitor human%" OR LOWER(tradeNames_string) LI... | [{'UUID': 'DrugGeneTargets_v2_2772', 'drugName': '.Alpha.1-Proteinase Inhibitor Human', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'ELANE (ENSG00000197561)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.414 | Q59 | What is the genetic target of the small molecule drug Zoledronic Acid, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Zoledronic Acid is FDPS. Zoledronic Acid reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%zoledronic acid%" OR LOWER(tradeNames_string) LIKE "%zoledronic acid... | [{'UUID': 'DrugGeneTargets_v2_4706', 'drugName': 'Zoledronic Acid', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'FDPS (ENSG00000160752)', 'yearOfFirstApproval': 2001, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1615 | Q59 | What is the genetic target of the small molecule drug Crizotinib, and what is its status in clinical trials and FDA approval? | There are 4 genetic targets of the small molecule drug Crizotinib: MET, ALK, NPM1, and EML4. Crizotinib reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%crizotinib%" OR LOWER(tradeNames_string) LIKE "%crizotinib%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_5879', 'drugName': 'Crizotinib', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'MET (ENSG00000105976), ALK (ENSG00000171094), NPM1 (ENSG00000181163), EML4 (ENSG00000143924)', 'yearOfFirstApproval': 2011, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'Dru... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.687 | Q59 | What is the genetic target of the small molecule drug Birinapant, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Birinapant: BIRC3 and BIRC2. Birinapant reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%birinapant%" OR LOWER(tradeNames_string) LIKE "%birinapant%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_267', 'drugName': 'Birinapant', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'BIRC3 (ENSG00000023445), BIRC2 (ENSG00000110330)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.621 | Q59 | What is the genetic target of the small molecule drug Cediranib, and what is its status in clinical trials and FDA approval? | There are 6 genetic targets of the small molecule drug Cediranib: FLT1, FLT4, KDR, KIT, PDGFRB, and PDGFRA. Cediranib reached phase 3 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%cediranib%" OR LOWER(tradeNames_string) LIKE "%cediranib%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_948', 'drugName': 'Cediranib', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'FLT1 (ENSG00000102755), FLT4 (ENSG00000037280), KDR (ENSG00000128052), KIT (ENSG00000157404), PDGFRB (ENSG00000113721), PDGFRA (ENSG00000134853)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPh... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.923 | Q59 | What is the genetic target of the small molecule drug Daunorubicin, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Daunorubicin is TOP2A. Daunorubicin reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%daunorubicin%" OR LOWER(tradeNames_string) LIKE "%daunorubicin%" OR ... | [{'UUID': 'DrugGeneTargets_v2_1919', 'drugName': 'Daunorubicin Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'TOP2A (ENSG00000131747)', 'yearOfFirstApproval': 1979, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_484', 'drugName': 'Doxorubicin', 'dru... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1199 | Q59 | What is the genetic target of the small molecule drug Bromfenac Sodium, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Bromfenac Sodium: PTGS2 and PTGS1. Bromfenac Sodium reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%bromfenac sodium%" OR LOWER(tradeNames_string) LIKE "%bromfenac sodi... | [{'UUID': 'DrugGeneTargets_v2_989', 'drugName': 'Bromfenac Sodium', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PTGS2 (ENSG00000073756), PTGS1 (ENSG00000095303)', 'yearOfFirstApproval': 1997, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.839 | Q59 | What is the genetic target of the small molecule drug Irinotecan Hydrochloride, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Irinotecan Hydrochloride is TOP1. Irinotecan Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%irinotecan hydrochloride%" OR LOWER(tradeNames_string) LIKE "%irinot... | [{'UUID': 'DrugGeneTargets_v2_5193', 'drugName': 'Irinotecan Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'TOP1 (ENSG00000198900)', 'yearOfFirstApproval': 1996, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1771 | Q59 | What is the genetic target of the small molecule drug Propantheline, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Propantheline: CHRM1, CHRM2, and CHRM3. Propantheline reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%propantheline%" OR LOWER(tradeNames_string) LIKE "%propantheline%" O... | [{'UUID': 'DrugGeneTargets_v2_4311', 'drugName': 'Propantheline Bromide', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CHRM3 (ENSG00000133019), CHRM1 (ENSG00000168539), CHRM2 (ENSG00000181072)', 'yearOfFirstApproval': 1953, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTar... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.953 | Q59 | What is the genetic target of the small molecule drug Miglustat, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Miglustat is UGCG. Miglustat reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%miglustat%" OR LOWER(tradeNames_string) LIKE "%miglustat%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_5675', 'drugName': 'Miglustat', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'UGCG (ENSG00000148154)', 'yearOfFirstApproval': 2003, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.185 | Q59 | What is the genetic target of the small molecule drug Nitrendipine, and what is its status in clinical trials and FDA approval? | There are 4 genetic targets of the small molecule drug Nitrendipine: CACNA1C, CACNA1S, CACNA1D, and CACNA1F. Nitrendipine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%nitrendipine%" OR LOWER(tradeNames_string) LIKE "%nitrendipine%" OR ... | [{'UUID': 'DrugGeneTargets_v2_1575', 'drugName': 'Nitrendipine', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CACNA1C (ENSG00000151067), CACNA1S (ENSG00000081248), CACNA1D (ENSG00000157388), CACNA1F (ENSG00000102001)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1072 | Q59 | What is the genetic target of the small molecule drug Hydromorphone, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Hydromorphone is OPRM1. Hydromorphone reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%hydromorphone%" OR LOWER(tradeNames_string) LIKE "%hydromorphone%" O... | [{'UUID': 'DrugGeneTargets_v2_245', 'drugName': 'Morphine', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'OPRM1 (ENSG00000112038)', 'yearOfFirstApproval': 1984, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_3034', 'drugName': 'Hydromorphone', 'drugMolecularType':... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.711 | Q59 | What is the genetic target of the small molecule drug Anileridine, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Anileridine: OPRM1 and OPRK1. Anileridine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%anileridine%" OR LOWER(tradeNames_string) LIKE "%anileridine%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_4939', 'drugName': 'Anileridine Phosphate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'OPRM1 (ENSG00000112038), OPRK1 (ENSG00000082556)', 'yearOfFirstApproval': 1982, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_1554', 'drugName'... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.173 | Q59 | What is the genetic target of the small molecule drug Sivelestat, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Sivelestat is ELANE. Sivelestat reached phase 3 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%sivelestat%" OR LOWER(tradeNames_string) LIKE "%sivelestat%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_3534', 'drugName': 'Sivelestat', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ELANE (ENSG00000197561)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 3, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.296 | Q59 | What is the genetic target of the small molecule drug Promethazine Hydrochloride, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Promethazine Hydrochloride is HRH1. Promethazine Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%promethazine hydrochloride%" OR LOWER(tradeNames_string) LIKE "%prom... | [{'UUID': 'DrugGeneTargets_v2_4426', 'drugName': 'Promethazine Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HRH1 (ENSG00000196639)', 'yearOfFirstApproval': 1951, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.554 | Q59 | What is the genetic target of the small molecule drug Fluphenazine Enanthate, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Fluphenazine Enanthate is DRD2. Fluphenazine Enanthate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%fluphenazine enanthate%" OR LOWER(tradeNames_string) LIKE "%fluphena... | [{'UUID': 'DrugGeneTargets_v2_905', 'drugName': 'Fluphenazine Enanthate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'DRD2 (ENSG00000149295)', 'yearOfFirstApproval': 1967, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.763 | Q59 | What is the genetic target of the oligonucleotide drug Inclisiran, and what is its status in clinical trials and FDA approval? | The genetic target of the oligonucleotide drug Inclisiran is PCSK9. Inclisiran reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%inclisiran%" OR LOWER(tradeNames_string) LIKE "%inclisiran%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_859', 'drugName': 'Inclisiran', 'drugMolecularType': 'Oligonucleotide', 'newLinkedTargets_string': 'PCSK9 (ENSG00000169174)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4738', 'drugName': 'Inclisiran Sodium', 'drugMolecularTy... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.304 | Q59 | What is the genetic target of the small molecule drug Levobunolol, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Levobunolol: ADRB2 and ADRB1. Levobunolol reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%levobunolol%" OR LOWER(tradeNames_string) LIKE "%levobunolol%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_1444', 'drugName': 'Levobunolol', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ADRB2 (ENSG00000169252), ADRB1 (ENSG00000043591)', 'yearOfFirstApproval': 1985, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_1443', 'drugName': 'Levobun... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1878 | Q59 | What is the genetic target of the small molecule drug Anagrelide Hydrochloride, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Anagrelide Hydrochloride: PDE3A and PDE3B. Anagrelide Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%anagrelide hydrochloride%" OR LOWER(tradeNames_string) LIKE "%anagre... | [{'UUID': 'DrugGeneTargets_v2_350', 'drugName': 'Anagrelide Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PDE3A (ENSG00000172572), PDE3B (ENSG00000152270)', 'yearOfFirstApproval': 1997, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1093 | Q59 | What is the genetic target of the small molecule drug Proparacaine, and what is its status in clinical trials and FDA approval? | There are 10 genetic targets of the small molecule drug Proparacaine: SCN1A, SCN5A, SCN4A, SCN7A, SCN2A, SCN9A, SCN3A, SCN11A, SCN8A, and SCN10A. Proparacaine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%proparacaine%" OR LOWER(tradeNames_string) LIKE "%proparacaine%" OR ... | [{'UUID': 'DrugGeneTargets_v2_6139', 'drugName': 'Proparacaine', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SCN1A (ENSG00000144285), SCN5A (ENSG00000183873), SCN4A (ENSG00000007314), SCN7A (ENSG00000136546), SCN2A (ENSG00000136531), SCN9A (ENSG00000169432), SCN3A (ENSG00000153253), SCN11A (ENSG0... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1747 | Q59 | What is the genetic target of the small molecule drug Treprostinil, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Treprostinil is PTGIR. Treprostinil reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%treprostinil%" OR LOWER(tradeNames_string) LIKE "%treprostinil%" OR ... | [{'UUID': 'DrugGeneTargets_v2_1758', 'drugName': 'Treprostinil', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PTGIR (ENSG00000160013)', 'yearOfFirstApproval': 2002, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_2433', 'drugName': 'Treprostinil Diolamine', 'drugM... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1652 | Q59 | What is the genetic target of the protein drug Insulin Lispro, and what is its status in clinical trials and FDA approval? | The genetic target of the protein drug Insulin Lispro is INSR. Insulin Lispro reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%insulin lispro%" OR LOWER(tradeNames_string) LIKE "%insulin lispro%"... | [{'UUID': 'DrugGeneTargets_v2_578', 'drugName': 'Insulin Lispro', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'INSR (ENSG00000171105)', 'yearOfFirstApproval': 1996, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5121', 'drugName': 'Insulin Lispro Protamine Recombinant',... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.914 | Q59 | What is the genetic target of the protein drug Insulin Lispro Protamine Recombinant, and what is its status in clinical trials and FDA approval? | The genetic target of the protein drug Insulin Lispro Protamine Recombinant is INSR. Insulin Lispro Protamine Recombinant reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%insulin lispro protamine recombinant%" OR LOWER(tradeNames_string) L... | [{'UUID': 'DrugGeneTargets_v2_5121', 'drugName': 'Insulin Lispro Protamine Recombinant', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'INSR (ENSG00000171105)', 'yearOfFirstApproval': 1999, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1932 | Q59 | What is the genetic target of the antibody drug Natalizumab, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the antibody drug Natalizumab: ITGA4, ITGB7, and ITGB1. Natalizumab reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%natalizumab%" OR LOWER(tradeNames_string) LIKE "%natalizumab%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_5015', 'drugName': 'Natalizumab', 'drugMolecularType': 'Antibody', 'newLinkedTargets_string': 'ITGA4 (ENSG00000115232), ITGB7 (ENSG00000139626), ITGB1 (ENSG00000150093)', 'yearOfFirstApproval': 2004, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5016', '... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.275 | Q59 | What is the genetic target of the small molecule drug Dersimelagon, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Dersimelagon is MC1R. Dersimelagon reached phase 3 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%dersimelagon%" OR LOWER(tradeNames_string) LIKE "%dersimelagon%" OR ... | [{'UUID': 'DrugGeneTargets_v2_935', 'drugName': 'Dersimelagon', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'MC1R (ENSG00000258839)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 3, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1147 | Q59 | What is the genetic target of the small molecule drug Triamcinolone, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Triamcinolone is NR3C1. Triamcinolone reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%triamcinolone%" OR LOWER(tradeNames_string) LIKE "%triamcinolone%" O... | [{'UUID': 'DrugGeneTargets_v2_4745', 'drugName': 'Triamcinolone Diacetate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'NR3C1 (ENSG00000113580)', 'yearOfFirstApproval': 1959, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_2041', 'drugName': 'Triamcinolone', 'dru... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1589 | Q59 | What is the genetic target of the small molecule drug Asp-3026, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Asp-3026 is ALK. Asp-3026 reached phase 1 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%asp-3026%" OR LOWER(tradeNames_string) LIKE "%asp-3026%" OR LOWER(dr... | [{'UUID': 'DrugGeneTargets_v2_3702', 'drugName': 'Asp-3026', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ALK (ENSG00000171094)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 1, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.700 | Q59 | What is the genetic target of the small molecule drug Hexafluorenium, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Hexafluorenium is ACHE. Hexafluorenium reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%hexafluorenium%" OR LOWER(tradeNames_string) LIKE "%hexafluorenium%"... | [{'UUID': 'DrugGeneTargets_v2_4011', 'drugName': 'Hexafluorenium', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ACHE (ENSG00000087085)', 'yearOfFirstApproval': 1982, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4592', 'drugName': 'Hexafluorenium Bromide', 'drug... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1765 | Q59 | What is the genetic target of the small molecule drug Dipivefrin Hydrochloride, and what is its status in clinical trials and FDA approval? | There are 9 genetic targets of the small molecule drug Dipivefrin Hydrochloride: ADRA1A, ADRA2A, ADRB1, ADRB2, ADRA2C, ADRA1D, ADRA1B, ADRA2B, and ADRB3. Dipivefrin Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%dipivefrin hydrochloride%" OR LOWER(tradeNames_string) LIKE "%dipive... | [{'UUID': 'DrugGeneTargets_v2_1692', 'drugName': 'Dipivefrin Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ADRA1A (ENSG00000120907), ADRA2A (ENSG00000150594), ADRB1 (ENSG00000043591), ADRB2 (ENSG00000169252), ADRA2C (ENSG00000184160), ADRA1D (ENSG00000171873), ADRA1B (ENSG0000017021... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.488 | Q59 | What is the genetic target of the small molecule drug Betaxolol Hydrochloride, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Betaxolol Hydrochloride is ADRB1. Betaxolol Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%betaxolol hydrochloride%" OR LOWER(tradeNames_string) LIKE "%betaxol... | [{'UUID': 'DrugGeneTargets_v2_3151', 'drugName': 'Betaxolol Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ADRB1 (ENSG00000043591)', 'yearOfFirstApproval': 1985, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_2237', 'drugName': 'Levobetaxolol Hydroc... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.428 | Q59 | What is the genetic target of the small molecule drug Vonoprazan Fumarate, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Vonoprazan Fumarate: ATP4A and ATP4B. Vonoprazan Fumarate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%vonoprazan fumarate%" OR LOWER(tradeNames_string) LIKE "%vonoprazan ... | [{'UUID': 'DrugGeneTargets_v2_5640', 'drugName': 'Vonoprazan Fumarate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ATP4A (ENSG00000105675), ATP4B (ENSG00000186009)', 'yearOfFirstApproval': 2022, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.377 | Q59 | What is the genetic target of the small molecule drug Fexofenadine Hydrochloride, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Fexofenadine Hydrochloride is HRH1. Fexofenadine Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%fexofenadine hydrochloride%" OR LOWER(tradeNames_string) LIKE "%fexo... | [{'UUID': 'DrugGeneTargets_v2_1045', 'drugName': 'Fexofenadine Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HRH1 (ENSG00000196639)', 'yearOfFirstApproval': 1996, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1008 | Q59 | What is the genetic target of the antibody drug Rituximab, and what is its status in clinical trials and FDA approval? | The genetic target of the antibody drug Rituximab is MS4A1. Rituximab reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%rituximab%" OR LOWER(tradeNames_string) LIKE "%rituximab%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_4195', 'drugName': 'Rituximab', 'drugMolecularType': 'Antibody', 'newLinkedTargets_string': 'MS4A1 (ENSG00000156738)', 'yearOfFirstApproval': 1997, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1003 | Q59 | What is the genetic target of the oligonucleotide drug Lumasiran, and what is its status in clinical trials and FDA approval? | The genetic target of the oligonucleotide drug Lumasiran is HAO1. Lumasiran reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%lumasiran%" OR LOWER(tradeNames_string) LIKE "%lumasiran%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_1382', 'drugName': 'Lumasiran', 'drugMolecularType': 'Oligonucleotide', 'newLinkedTargets_string': 'HAO1 (ENSG00000101323)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_1071', 'drugName': 'Lumasiran Sodium', 'drugMolecularType... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1940 | Q59 | What is the genetic target of the protein drug Calcitonin Salmon Recombinant, and what is its status in clinical trials and FDA approval? | The genetic target of the protein drug Calcitonin Salmon Recombinant is CALCR. Calcitonin Salmon Recombinant reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%calcitonin salmon recombinant%" OR LOWER(tradeNames_string) LIKE "%c... | [{'UUID': 'DrugGeneTargets_v2_4748', 'drugName': 'Calcitonin Salmon Recombinant', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'CALCR (ENSG00000004948)', 'yearOfFirstApproval': 2005, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.714 | Q59 | What is the genetic target of the small molecule drug Canagliflozin, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Canagliflozin is SLC5A2. Canagliflozin reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%canagliflozin%" OR LOWER(tradeNames_string) LIKE "%canagliflozin%" O... | [{'UUID': 'DrugGeneTargets_v2_4559', 'drugName': 'Canagliflozin', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SLC5A2 (ENSG00000140675)', 'yearOfFirstApproval': 2011, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_6346', 'drugName': 'Canagliflozin', 'drugMolecula... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1335 | Q59 | What is the genetic target of the small molecule drug Bitolterol, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Bitolterol is ADRB2. Bitolterol reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%bitolterol%" OR LOWER(tradeNames_string) LIKE "%bitolterol%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_5529', 'drugName': 'Bitolterol', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ADRB2 (ENSG00000169252)', 'yearOfFirstApproval': 1984, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_3535', 'drugName': 'Bitolterol Mesylate', 'drugMolecu... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1156 | Q59 | What is the genetic target of the small molecule drug Bi-811283, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Bi-811283 is AURKB. Bi-811283 reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%bi-811283%" OR LOWER(tradeNames_string) LIKE "%bi-811283%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_1351', 'drugName': 'Bi-811283', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'AURKB (ENSG00000178999)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.338 | Q59 | What is the genetic target of the small molecule drug Butorphanol Tartrate, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Butorphanol Tartrate: OPRM1 and OPRK1. Butorphanol Tartrate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%butorphanol tartrate%" OR LOWER(tradeNames_string) LIKE "%butorphano... | [{'UUID': 'DrugGeneTargets_v2_1672', 'drugName': 'Butorphanol Tartrate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'OPRM1 (ENSG00000112038), OPRK1 (ENSG00000082556)', 'yearOfFirstApproval': 1978, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_1673', 'drugName':... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1343 | Q59 | What is the genetic target of the small molecule drug Melatonin, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Melatonin: MTNR1A and MTNR1B. Melatonin reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%melatonin%" OR LOWER(tradeNames_string) LIKE "%melatonin%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_5737', 'drugName': 'Melatonin', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'MTNR1A (ENSG00000168412), MTNR1B (ENSG00000134640)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1593 | Q59 | What is the genetic target of the small molecule drug Cr-6086, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Cr-6086 is PTGER4. Cr-6086 reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%cr-6086%" OR LOWER(tradeNames_string) LIKE "%cr-6086%" OR LOWER(drug... | [{'UUID': 'DrugGeneTargets_v2_4531', 'drugName': 'Cr-6086', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PTGER4 (ENSG00000171522)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1993 | Q59 | What is the genetic target of the small molecule drug Ropinirole Hydrochloride, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Ropinirole Hydrochloride: DRD2, DRD3, and DRD4. Ropinirole Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ropinirole hydrochloride%" OR LOWER(tradeNames_string) LIKE "%ropini... | [{'UUID': 'DrugGeneTargets_v2_1840', 'drugName': 'Ropinirole Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'DRD2 (ENSG00000149295), DRD3 (ENSG00000151577), DRD4 (ENSG00000069696)', 'yearOfFirstApproval': 1997, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.598 | Q59 | What is the genetic target of the antibody drug Tb-403, and what is its status in clinical trials and FDA approval? | The genetic target of the antibody drug Tb-403 is PGF. Tb-403 reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%tb-403%" OR LOWER(tradeNames_string) LIKE "%tb-403%" OR LOWER(drugSy... | [{'UUID': 'DrugGeneTargets_v2_3688', 'drugName': 'Tb-403', 'drugMolecularType': 'Antibody', 'newLinkedTargets_string': 'PGF (ENSG00000119630)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.16 | Q59 | What is the genetic target of the small molecule drug Baricitinib, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Baricitinib: JAK2 and JAK1. Baricitinib reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%baricitinib%" OR LOWER(tradeNames_string) LIKE "%baricitinib%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_1303', 'drugName': 'Baricitinib', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'JAK2 (ENSG00000096968), JAK1 (ENSG00000162434)', 'yearOfFirstApproval': 2018, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_1304', 'drugName': 'Baricitin... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1855 | Q59 | What is the genetic target of the small molecule drug Silodosin, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Silodosin is ADRA1A. Silodosin reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%silodosin%" OR LOWER(tradeNames_string) LIKE "%silodosin%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_557', 'drugName': 'Silodosin', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ADRA1A (ENSG00000120907)', 'yearOfFirstApproval': 2008, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1634 | Q59 | What is the genetic target of the small molecule drug Molindone, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Molindone: HTR2A and DRD2. Molindone reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%molindone%" OR LOWER(tradeNames_string) LIKE "%molindone%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_789', 'drugName': 'Molindone', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HTR2A (ENSG00000102468), DRD2 (ENSG00000149295)', 'yearOfFirstApproval': 1974, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_788', 'drugName': 'Molindone', ... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1686 | Q59 | What is the genetic target of the small molecule drug Acetyldigitoxin, and what is its status in clinical trials and FDA approval? | There are 8 genetic targets of the small molecule drug Acetyldigitoxin: ATP1A1, ATP1B2, ATP1B1, ATP1A2, ATP1B3, ATP1A3, ATP1A4, and FXYD2. Acetyldigitoxin reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%acetyldigitoxin%" OR LOWER(tradeNames_string) LIKE "%acetyldigitoxin... | [{'UUID': 'DrugGeneTargets_v2_1212', 'drugName': 'Acetyldigitoxin', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ATP1A1 (ENSG00000163399), ATP1B2 (ENSG00000129244), ATP1B1 (ENSG00000143153), ATP1A2 (ENSG00000018625), ATP1B3 (ENSG00000069849), ATP1A3 (ENSG00000105409), ATP1A4 (ENSG00000132681), FXY... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.600 | Q59 | What is the genetic target of the protein drug Plecanatide, and what is its status in clinical trials and FDA approval? | The genetic target of the protein drug Plecanatide is GUCY2C. Plecanatide reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%plecanatide%" OR LOWER(tradeNames_string) LIKE "%plecanatide%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_5758', 'drugName': 'Plecanatide', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'GUCY2C (ENSG00000070019)', 'yearOfFirstApproval': 2017, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.924 | Q59 | What is the genetic target of the small molecule drug Sitaxentan Sodium, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Sitaxentan Sodium: EDNRB and EDNRA. Sitaxentan Sodium reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%sitaxentan sodium%" OR LOWER(tradeNames_string) LIKE "%sitaxentan so... | [{'UUID': 'DrugGeneTargets_v2_5500', 'drugName': 'Sitaxentan Sodium', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'EDNRB (ENSG00000136160), EDNRA (ENSG00000151617)', 'yearOfFirstApproval': 2006, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.471 | Q59 | What is the genetic target of the small molecule drug Propoxycaine Hydrochloride, and what is its status in clinical trials and FDA approval? | There are 10 genetic targets of the small molecule drug Propoxycaine Hydrochloride: SCN1A, SCN5A, SCN4A, SCN7A, SCN2A, SCN9A, SCN3A, SCN11A, SCN8A, and SCN10A. Propoxycaine Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%propoxycaine hydrochloride%" OR LOWER(tradeNames_string) LIKE "%prop... | [{'UUID': 'DrugGeneTargets_v2_1701', 'drugName': 'Propoxycaine Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SCN1A (ENSG00000144285), SCN5A (ENSG00000183873), SCN4A (ENSG00000007314), SCN7A (ENSG00000136546), SCN2A (ENSG00000136531), SCN9A (ENSG00000169432), SCN3A (ENSG00000153253),... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.202 | Q59 | What is the genetic target of the small molecule drug Ticlopidine, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Ticlopidine is P2RY12. Ticlopidine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ticlopidine%" OR LOWER(tradeNames_string) LIKE "%ticlopidine%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_3795', 'drugName': 'Ticlopidine', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'P2RY12 (ENSG00000169313)', 'yearOfFirstApproval': 1991, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_1201', 'drugName': 'Ticlopidine Hydrochloride', 'dr... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1206 | Q59 | What is the genetic target of the protein drug Tesamorelin, and what is its status in clinical trials and FDA approval? | The genetic target of the protein drug Tesamorelin is GHRHR. Tesamorelin reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%tesamorelin%" OR LOWER(tradeNames_string) LIKE "%tesamorelin%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_2825', 'drugName': 'Tesamorelin', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'GHRHR (ENSG00000106128)', 'yearOfFirstApproval': 2010, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4100', 'drugName': 'Tesamorelin Acetate', 'drugMolecularTyp... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1056 | Q59 | What is the genetic target of the small molecule drug Qaf805, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Qaf805: ADORA3 and ADORA2B. Qaf805 reached phase 1 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%qaf805%" OR LOWER(tradeNames_string) LIKE "%qaf805%" OR LOWER(drugSy... | [{'UUID': 'DrugGeneTargets_v2_5644', 'drugName': 'Qaf805', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ADORA3 (ENSG00000282608), ADORA2B (ENSG00000170425)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 1, 'drugIsApproved': False}, {'UUID': 'DrugGeneTargets_v2_5645', 'drugName': 'Qaf805', 'd... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1195 | Q59 | What is the genetic target of the small molecule drug Sertraline Hydrochloride, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Sertraline Hydrochloride is SLC6A4. Sertraline Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%sertraline hydrochloride%" OR LOWER(tradeNames_string) LIKE "%sertra... | [{'UUID': 'DrugGeneTargets_v2_464', 'drugName': 'Sertraline Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SLC6A4 (ENSG00000108576)', 'yearOfFirstApproval': 1991, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1300 | Q59 | What is the genetic target of the small molecule drug Fenoldopam Mesylate, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Fenoldopam Mesylate is DRD1. Fenoldopam Mesylate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%fenoldopam mesylate%" OR LOWER(tradeNames_string) LIKE "%fenoldopam ... | [{'UUID': 'DrugGeneTargets_v2_4006', 'drugName': 'Fenoldopam Mesylate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'DRD1 (ENSG00000184845)', 'yearOfFirstApproval': 1997, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1276 | Q59 | What is the genetic target of the small molecule drug Ketamine Hydrochloride, and what is its status in clinical trials and FDA approval? | There are 7 genetic targets of the small molecule drug Ketamine Hydrochloride: GRIN1, GRIN2A, GRIN2B, GRIN2D, GRIN3B, GRIN2C, and GRIN3A. Ketamine Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ketamine hydrochloride%" OR LOWER(tradeNames_string) LIKE "%ketamine... | [{'UUID': 'DrugGeneTargets_v2_1959', 'drugName': 'Ketamine Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'GRIN1 (ENSG00000176884), GRIN2A (ENSG00000183454), GRIN2B (ENSG00000273079), GRIN2D (ENSG00000105464), GRIN3B (ENSG00000116032), GRIN2C (ENSG00000161509), GRIN3A (ENSG00000198785... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1814 | Q59 | What is the genetic target of the antibody drug Tomaralimab, and what is its status in clinical trials and FDA approval? | The genetic target of the antibody drug Tomaralimab is TLR2. Tomaralimab reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%tomaralimab%" OR LOWER(tradeNames_string) LIKE "%tomaralimab%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_5402', 'drugName': 'Tomaralimab', 'drugMolecularType': 'Antibody', 'newLinkedTargets_string': 'TLR2 (ENSG00000137462)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1402 | Q59 | What is the genetic target of the small molecule drug Piroxicam, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Piroxicam: PTGS2 and PTGS1. Piroxicam reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%piroxicam%" OR LOWER(tradeNames_string) LIKE "%piroxicam%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_2069', 'drugName': 'Piroxicam', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PTGS2 (ENSG00000073756), PTGS1 (ENSG00000095303)', 'yearOfFirstApproval': 1982, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1807 | Q59 | What is the genetic target of the small molecule drug Hydrocodone Bitartrate, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Hydrocodone Bitartrate: OPRK1, OPRD1, and OPRM1. Hydrocodone Bitartrate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%hydrocodone bitartrate%" OR LOWER(tradeNames_string) LIKE "%hydrocod... | [{'UUID': 'DrugGeneTargets_v2_2476', 'drugName': 'Hydrocodone Bitartrate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'OPRK1 (ENSG00000082556), OPRD1 (ENSG00000116329), OPRM1 (ENSG00000112038)', 'yearOfFirstApproval': 1943, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.661 | Q59 | What is the genetic target of the small molecule drug Propoxyphene, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Propoxyphene is OPRM1. Propoxyphene reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%propoxyphene%" OR LOWER(tradeNames_string) LIKE "%propoxyphene%" OR ... | [{'UUID': 'DrugGeneTargets_v2_1331', 'drugName': 'Propoxyphene', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'OPRM1 (ENSG00000112038)', 'yearOfFirstApproval': 1957, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_3834', 'drugName': 'Propoxyphene Hydrochloride', 'd... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.560 | Q59 | What is the genetic target of the small molecule drug Oglemilast, and what is its status in clinical trials and FDA approval? | There are 4 genetic targets of the small molecule drug Oglemilast: PDE4A, PDE4D, PDE4B, and PDE4C. Oglemilast reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%oglemilast%" OR LOWER(tradeNames_string) LIKE "%oglemilast%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_2650', 'drugName': 'Oglemilast', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PDE4A (ENSG00000065989), PDE4D (ENSG00000113448), PDE4B (ENSG00000184588), PDE4C (ENSG00000105650)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.44 | Q59 | What is the genetic target of the small molecule drug Trilaciclib, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Trilaciclib: CDK6 and CDK4. Trilaciclib reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%trilaciclib%" OR LOWER(tradeNames_string) LIKE "%trilaciclib%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_171', 'drugName': 'Trilaciclib', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CDK6 (ENSG00000105810), CDK4 (ENSG00000135446)', 'yearOfFirstApproval': 2021, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_170', 'drugName': 'Trilaciclib... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.278 | Q59 | What is the genetic target of the small molecule drug Dantrolene, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Dantrolene: RYR3 and RYR1. Dantrolene reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%dantrolene%" OR LOWER(tradeNames_string) LIKE "%dantrolene%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_4505', 'drugName': 'Dantrolene Sodium', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'RYR3 (ENSG00000198838), RYR1 (ENSG00000196218)', 'yearOfFirstApproval': 1974, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_4504', 'drugName': 'Dan... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1096 | Q59 | What is the genetic target of the small molecule drug Paxalisib, and what is its status in clinical trials and FDA approval? | There are 8 genetic targets of the small molecule drug Paxalisib: PIK3R1, PIK3CB, PIK3CG, PIK3CA, PIK3R2, PIK3CD, PIK3R5, and PIK3R3. Paxalisib reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%paxalisib%" OR LOWER(tradeNames_string) LIKE "%paxalisib%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_1740', 'drugName': 'Paxalisib', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PIK3R1 (ENSG00000145675), PIK3CB (ENSG00000051382), PIK3CG (ENSG00000105851), PIK3CA (ENSG00000121879), PIK3R2 (ENSG00000105647), PIK3CD (ENSG00000171608), PIK3R5 (ENSG00000141506), PIK3R3 (E... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.104 | Q59 | What is the genetic target of the small molecule drug Zolpidem, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Zolpidem: GABRA1, GABRG2, and GABRB1. Zolpidem reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%zolpidem%" OR LOWER(tradeNames_string) LIKE "%zolpidem%" OR LOWER(dr... | [{'UUID': 'DrugGeneTargets_v2_4503', 'drugName': 'Zolpidem', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'GABRA1 (ENSG00000022355), GABRG2 (ENSG00000113327), GABRB1 (ENSG00000163288)', 'yearOfFirstApproval': 1992, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_59... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.856 | Q59 | What is the genetic target of the protein drug Gonadorelin Hydrochloride, and what is its status in clinical trials and FDA approval? | The genetic target of the protein drug Gonadorelin Hydrochloride is GNRHR. Gonadorelin Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%gonadorelin hydrochloride%" OR LOWER(tradeNames_string) LIKE "%gonad... | [{'UUID': 'DrugGeneTargets_v2_5262', 'drugName': 'Gonadorelin Hydrochloride', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'GNRHR (ENSG00000109163)', 'yearOfFirstApproval': 1982, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.985 | Q59 | What is the genetic target of the small molecule drug Ertugliflozin, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Ertugliflozin is SLC5A2. Ertugliflozin reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%ertugliflozin%" OR LOWER(tradeNames_string) LIKE "%ertugliflozin%" O... | [{'UUID': 'DrugGeneTargets_v2_3216', 'drugName': 'Ertugliflozin', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SLC5A2 (ENSG00000140675)', 'yearOfFirstApproval': 2017, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.948 | Q59 | What is the genetic target of the small molecule drug Azd-4017, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Azd-4017 is HSD11B1. Azd-4017 reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%azd-4017%" OR LOWER(tradeNames_string) LIKE "%azd-4017%" OR LOWER(dr... | [{'UUID': 'DrugGeneTargets_v2_3096', 'drugName': 'Azd-4017', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HSD11B1 (ENSG00000117594)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.110 | Q59 | What is the genetic target of the small molecule drug Diflunisal, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Diflunisal: PTGS2 and PTGS1. Diflunisal reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%diflunisal%" OR LOWER(tradeNames_string) LIKE "%diflunisal%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_602', 'drugName': 'Diflunisal', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PTGS2 (ENSG00000073756), PTGS1 (ENSG00000095303)', 'yearOfFirstApproval': 1982, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1296 | Q59 | What is the genetic target of the small molecule drug Dolasetron Mesylate, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Dolasetron Mesylate is HTR3A. Dolasetron Mesylate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%dolasetron mesylate%" OR LOWER(tradeNames_string) LIKE "%dolasetron ... | [{'UUID': 'DrugGeneTargets_v2_2936', 'drugName': 'Dolasetron Mesylate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HTR3A (ENSG00000166736)', 'yearOfFirstApproval': 1997, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.503 | Q59 | What is the genetic target of the small molecule drug Methantheline, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Methantheline is HRH2. Methantheline reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%methantheline%" OR LOWER(tradeNames_string) LIKE "%methantheline%" O... | [{'UUID': 'DrugGeneTargets_v2_3052', 'drugName': 'Methantheline', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HRH2 (ENSG00000113749)', 'yearOfFirstApproval': 1951, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_3603', 'drugName': 'Methantheline Bromide', 'drugMo... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1981 | Q59 | What is the genetic target of the small molecule drug Naratriptan Hydrochloride, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Naratriptan Hydrochloride: HTR1B and HTR1D. Naratriptan Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%naratriptan hydrochloride%" OR LOWER(tradeNames_string) LIKE "%narat... | [{'UUID': 'DrugGeneTargets_v2_5845', 'drugName': 'Naratriptan Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HTR1B (ENSG00000135312), HTR1D (ENSG00000179546)', 'yearOfFirstApproval': 1998, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5846', 'drugN... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.869 | Q59 | What is the genetic target of the small molecule drug Cetirizine Hydrochloride, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Cetirizine Hydrochloride is HRH1. Cetirizine Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%cetirizine hydrochloride%" OR LOWER(tradeNames_string) LIKE "%cetiri... | [{'UUID': 'DrugGeneTargets_v2_6377', 'drugName': 'Cetirizine Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HRH1 (ENSG00000196639)', 'yearOfFirstApproval': 1995, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_5631', 'drugName': 'Levocetirizine Dihyd... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.748 | Q59 | What is the genetic target of the small molecule drug Oxyphenbutazone, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Oxyphenbutazone: PTGS2 and PTGS1. Oxyphenbutazone reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%oxyphenbutazone%" OR LOWER(tradeNames_string) LIKE "%oxyphenbutazone... | [{'UUID': 'DrugGeneTargets_v2_4669', 'drugName': 'Oxyphenbutazone', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PTGS2 (ENSG00000073756), PTGS1 (ENSG00000095303)', 'yearOfFirstApproval': 1960, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_172', 'drugName': 'Oxyp... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1015 | Q59 | What is the genetic target of the small molecule drug Propylthiouracil, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Propylthiouracil: TPO and DIO1. Propylthiouracil reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%propylthiouracil%" OR LOWER(tradeNames_string) LIKE "%propylthiourac... | [{'UUID': 'DrugGeneTargets_v2_394', 'drugName': 'Propylthiouracil', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'TPO (ENSG00000115705), DIO1 (ENSG00000211452)', 'yearOfFirstApproval': 1947, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_395', 'drugName': 'Propylt... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1315 | Q59 | What is the genetic target of the small molecule drug Fluocinonide, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Fluocinonide is NR3C1. Fluocinonide reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%fluocinonide%" OR LOWER(tradeNames_string) LIKE "%fluocinonide%" OR ... | [{'UUID': 'DrugGeneTargets_v2_4918', 'drugName': 'Fluocinonide', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'NR3C1 (ENSG00000113580)', 'yearOfFirstApproval': 1971, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1297 | Q59 | What is the genetic target of the small molecule drug Capmatinib Hydrochloride, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Capmatinib Hydrochloride is MET. Capmatinib Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%capmatinib hydrochloride%" OR LOWER(tradeNames_string) LIKE "%capmat... | [{'UUID': 'DrugGeneTargets_v2_568', 'drugName': 'Capmatinib Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'MET (ENSG00000105976)', 'yearOfFirstApproval': 2020, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.609 | Q59 | What is the genetic target of the small molecule drug Encainide, and what is its status in clinical trials and FDA approval? | There are 10 genetic targets of the small molecule drug Encainide: SCN1A, SCN5A, SCN4A, SCN7A, SCN2A, SCN9A, SCN3A, SCN11A, SCN8A, and SCN10A. Encainide reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%encainide%" OR LOWER(tradeNames_string) LIKE "%encainide%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_4728', 'drugName': 'Encainide', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SCN1A (ENSG00000144285), SCN5A (ENSG00000183873), SCN4A (ENSG00000007314), SCN7A (ENSG00000136546), SCN2A (ENSG00000136531), SCN9A (ENSG00000169432), SCN3A (ENSG00000153253), SCN11A (ENSG0000... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1362 | Q59 | What is the genetic target of the small molecule drug Dextroamphetamine Sulfate, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Dextroamphetamine Sulfate: SLC6A2, SLC6A3, and SLC18A2. Dextroamphetamine Sulfate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%dextroamphetamine sulfate%" OR LOWER(tradeNames_string) LIKE "%dextr... | [{'UUID': 'DrugGeneTargets_v2_1031', 'drugName': 'Dextroamphetamine Sulfate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SLC6A2 (ENSG00000103546), SLC6A3 (ENSG00000142319), SLC18A2 (ENSG00000165646)', 'yearOfFirstApproval': 1960, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'Dru... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.75 | Q59 | What is the genetic target of the small molecule drug Alclofenac, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Alclofenac is PTGS1. Alclofenac reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%alclofenac%" OR LOWER(tradeNames_string) LIKE "%alclofenac%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_3320', 'drugName': 'Alclofenac', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'PTGS1 (ENSG00000095303)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1082 | Q59 | What is the genetic target of the small molecule drug Quetiapine Fumarate, and what is its status in clinical trials and FDA approval? | There are 3 genetic targets of the small molecule drug Quetiapine Fumarate: HTR2A, HTR2C, and DRD2. Quetiapine Fumarate reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%quetiapine fumarate%" OR LOWER(tradeNames_string) LIKE "%quetiapine ... | [{'UUID': 'DrugGeneTargets_v2_4441', 'drugName': 'Quetiapine Fumarate', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HTR2A (ENSG00000102468), HTR2C (ENSG00000147246), DRD2 (ENSG00000149295)', 'yearOfFirstApproval': 1997, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTarget... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1214 | Q59 | What is the genetic target of the small molecule drug Budesonide, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Budesonide is NR3C1. Budesonide reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%budesonide%" OR LOWER(tradeNames_string) LIKE "%budesonide%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_3329', 'drugName': 'Budesonide', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'NR3C1 (ENSG00000113580)', 'yearOfFirstApproval': 1994, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1167 | Q59 | What is the genetic target of the small molecule drug Dichlorobenzyl Alcohol, and what is its status in clinical trials and FDA approval? | There are 10 genetic targets of the small molecule drug Dichlorobenzyl Alcohol: SCN1A, SCN5A, SCN4A, SCN7A, SCN2A, SCN9A, SCN3A, SCN11A, SCN8A, and SCN10A. Dichlorobenzyl Alcohol reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%dichlorobenzyl alcohol%" OR LOWER(tradeNames_string) LIKE "%dichloro... | [{'UUID': 'DrugGeneTargets_v2_5003', 'drugName': 'Dichlorobenzyl Alcohol', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SCN1A (ENSG00000144285), SCN5A (ENSG00000183873), SCN4A (ENSG00000007314), SCN7A (ENSG00000136546), SCN2A (ENSG00000136531), SCN9A (ENSG00000169432), SCN3A (ENSG00000153253), SCN... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.625 | Q59 | What is the genetic target of the antibody drug Budigalimab, and what is its status in clinical trials and FDA approval? | The genetic target of the antibody drug Budigalimab is PDCD1. Budigalimab reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%budigalimab%" OR LOWER(tradeNames_string) LIKE "%budigalimab%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_6333', 'drugName': 'Budigalimab', 'drugMolecularType': 'Antibody', 'newLinkedTargets_string': 'PDCD1 (ENSG00000188389)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.487 | Q59 | What is the genetic target of the small molecule drug Diltiazem, and what is its status in clinical trials and FDA approval? | There are 4 genetic targets of the small molecule drug Diltiazem: CACNA1C, CACNA1S, CACNA1D, and CACNA1F. Diltiazem reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%diltiazem%" OR LOWER(tradeNames_string) LIKE "%diltiazem%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_927', 'drugName': 'Diltiazem Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CACNA1C (ENSG00000151067), CACNA1S (ENSG00000081248), CACNA1D (ENSG00000157388), CACNA1F (ENSG00000102001)', 'yearOfFirstApproval': 1982, 'maxClinicalTrialPhase': 4, 'drugIsAppro... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1579 | Q59 | What is the genetic target of the small molecule drug Gimatecan, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Gimatecan is TOP1. Gimatecan reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%gimatecan%" OR LOWER(tradeNames_string) LIKE "%gimatecan%" OR LOWER(... | [{'UUID': 'DrugGeneTargets_v2_1470', 'drugName': 'Gimatecan', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'TOP1 (ENSG00000198900)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.512 | Q59 | What is the genetic target of the small molecule drug Benziodarone, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Benziodarone is CALM1. Benziodarone reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%benziodarone%" OR LOWER(tradeNames_string) LIKE "%benziodarone%" OR ... | [{'UUID': 'DrugGeneTargets_v2_1971', 'drugName': 'Benziodarone', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CALM1 (ENSG00000198668)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.740 | Q59 | What is the genetic target of the small molecule drug Viloxazine Hydrochloride, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Viloxazine Hydrochloride is SLC6A2. Viloxazine Hydrochloride reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%viloxazine hydrochloride%" OR LOWER(tradeNames_string) LIKE "%viloxa... | [{'UUID': 'DrugGeneTargets_v2_5502', 'drugName': 'Viloxazine Hydrochloride', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SLC6A2 (ENSG00000103546)', 'yearOfFirstApproval': 2021, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.762 | Q59 | What is the genetic target of the small molecule drug Cinnarizine, and what is its status in clinical trials and FDA approval? | There are 5 genetic targets of the small molecule drug Cinnarizine: HRH1, CACNA1C, CACNA1S, CACNA1D, and CACNA1F. Cinnarizine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%cinnarizine%" OR LOWER(tradeNames_string) LIKE "%cinnarizine%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_4535', 'drugName': 'Cinnarizine', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HRH1 (ENSG00000196639), CACNA1C (ENSG00000151067), CACNA1S (ENSG00000081248), CACNA1D (ENSG00000157388), CACNA1F (ENSG00000102001)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 4, 'd... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1990 | Q59 | What is the genetic target of the small molecule drug Pantoprazole Sodium, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Pantoprazole Sodium: ATP4A and ATP4B. Pantoprazole Sodium reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%pantoprazole sodium%" OR LOWER(tradeNames_string) LIKE "%pantoprazol... | [{'UUID': 'DrugGeneTargets_v2_1903', 'drugName': 'Pantoprazole Sodium', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ATP4A (ENSG00000105675), ATP4B (ENSG00000186009)', 'yearOfFirstApproval': 2000, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.784 | Q59 | What is the genetic target of the small molecule drug Lorlatinib, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Lorlatinib: ALK and EML4. Lorlatinib reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%lorlatinib%" OR LOWER(tradeNames_string) LIKE "%lorlatinib%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_236', 'drugName': 'Lorlatinib', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'ALK (ENSG00000171094), EML4 (ENSG00000143924)', 'yearOfFirstApproval': 2018, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_237', 'drugName': 'Lorlatinib', ... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.1763 | Q59 | What is the genetic target of the small molecule drug Thiothixene, and what is its status in clinical trials and FDA approval? | There are 2 genetic targets of the small molecule drug Thiothixene: DRD2 and HTR2A. Thiothixene reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%thiothixene%" OR LOWER(tradeNames_string) LIKE "%thiothixene%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_2625', 'drugName': 'Thiothixene', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'DRD2 (ENSG00000149295), HTR2A (ENSG00000102468)', 'yearOfFirstApproval': 1967, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUID': 'DrugGeneTargets_v2_2624', 'drugName': 'Thiothix... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.848 | Q59 | What is the genetic target of the small molecule drug Tarafenacin, and what is its status in clinical trials and FDA approval? | The genetic target of the small molecule drug Tarafenacin is CHRM3. Tarafenacin reached phase 2 clinical trials but is not approved by the FDA for treatment of any disease. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%tarafenacin%" OR LOWER(tradeNames_string) LIKE "%tarafenacin%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_2787', 'drugName': 'Tarafenacin', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'CHRM3 (ENSG00000133019)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 2, 'drugIsApproved': False}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.315 | Q59 | What is the genetic target of the small molecule drug Lamotrigine, and what is its status in clinical trials and FDA approval? | There are 10 genetic targets of the small molecule drug Lamotrigine: SCN1A, SCN5A, SCN4A, SCN7A, SCN2A, SCN9A, SCN3A, SCN11A, SCN8A, and SCN10A. Lamotrigine reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%lamotrigine%" OR LOWER(tradeNames_string) LIKE "%lamotrigine%" OR LO... | [{'UUID': 'DrugGeneTargets_v2_5462', 'drugName': 'Lamotrigine', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'SCN1A (ENSG00000144285), SCN5A (ENSG00000183873), SCN4A (ENSG00000007314), SCN7A (ENSG00000136546), SCN2A (ENSG00000136531), SCN9A (ENSG00000169432), SCN3A (ENSG00000153253), SCN11A (ENSG00... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.816 | Q59 | What is the genetic target of the small molecule drug Nefazodone, and what is its status in clinical trials and FDA approval? | There are 4 genetic targets of the small molecule drug Nefazodone: HTR2C, SLC6A4, SLC6A2, and HTR2A. Nefazodone reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%nefazodone%" OR LOWER(tradeNames_string) LIKE "%nefazodone%" OR LOWE... | [{'UUID': 'DrugGeneTargets_v2_4082', 'drugName': 'Nefazodone', 'drugMolecularType': 'Small molecule', 'newLinkedTargets_string': 'HTR2C (ENSG00000147246), SLC6A4 (ENSG00000108576), SLC6A2 (ENSG00000103546), HTR2A (ENSG00000102468)', 'yearOfFirstApproval': 1994, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}, {'UUI... | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Q59.411 | Q59 | What is the genetic target of the protein drug Corifollitropin Alfa, and what is its status in clinical trials and FDA approval? | The genetic target of the protein drug Corifollitropin Alfa is FSHR. Corifollitropin Alfa reached phase 4 clinical trials meaning it has been approved by the FDA. | SELECT DISTINCT UUID, drugName, drugMolecularType, newLinkedTargets_string, yearOfFirstApproval, maxClinicalTrialPhase, drugIsApproved
FROM `{project_id}.{dataset_name}.DrugGeneTargets_ComprehensiveAnnotations_updated`
WHERE (LOWER(drugName) LIKE "%corifollitropin alfa%" OR LOWER(tradeNames_string) LIKE "%corifollit... | [{'UUID': 'DrugGeneTargets_v2_2306', 'drugName': 'Corifollitropin Alfa', 'drugMolecularType': 'Protein', 'newLinkedTargets_string': 'FSHR (ENSG00000170820)', 'yearOfFirstApproval': 0, 'maxClinicalTrialPhase': 4, 'drugIsApproved': True}] | general | Distinct, Similarity Search, Order By | Approval Status, Trial Phase, Genetic Target |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.